Award
Delivery Order #SPE2DR26FMKP6
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMKP6
NAICS
424210
This award represents a delivery order contract under a larger indefinite delivery vehicle (IDV) agreement with DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical services. The contract involves the procurement and delivery of Midazolam Hydrochloride, a crucial pharmaceutical product used widely in medical settings for sedation and anesthesia. The significance of this contract lies in ensuring timely supply of vital pharmaceuticals to support healthcare operations, enhancing the agency's medical readiness and patient care capability. The scope includes the prompt delivery of specified pharmaceuticals within a short, defined period. The parent IDV contract was competitively awarded, highlighting DMS Pharmaceutical Group's strong industry standing and capability. This specific delivery order continues the partnership, emphasizing an ongoing commitment to fulfill urgent pharmaceutical needs efficiently, with performance set within a concise timeframe in early 2026.
Description
4571171694! MIDAZOLAM HYDROCHLORI